Green Explo Inflammatory Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
About Green Explo Inflammatory
Green Explo Inflammatory Private Limited (GEIPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 2020 (Four years and one month 22 days old ). Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Lohia and Ram Pahan serve as directors at the Company.
Company Details
-
Location
Ranchi, Jharkhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24292JH2020PTC015675
-
Company No.
015675
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Dec 2020
-
Date of AGM
10 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Green Explo Inflammatory?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Lohia
|
Director | 09-Dec-2020 | Current |
|
Ram Pahan
|
Director | 09-Dec-2020 | Current |
Financial Performance of Green Explo Inflammatory.
Green Explo Inflammatory Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Explo Inflammatory?
Unlock access to Green Explo Inflammatory's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Immarat Engicon Private LimitedGopal Lohia and Ram Pahan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Explo Inflammatory?
Green Explo Inflammatory has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Explo Inflammatory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Explo Inflammatory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.